P95 BV (“P95”), a global leader in clinical and epidemiology research solutions, with a focus on vaccines and infectious diseases, is excited to announce the strategic acquisition of 4Clinics, a Contract Research Organization (CRO) providing Data Management, Biostatistics, Scientific Writing, Regulatory Affairs and Clinical Operations services for clinical and epidemiological studies with expertise in vaccines, immunotherapeutics and medical devices. P95 is a portfolio company of private equity firm Ampersand Capital Partners (“Ampersand”).
Read the full article: P95 Acquires 4Clinics to Expand Global CRO Services, Strengthen Position as Market Leader //
Source: https://www.prnewswire.com/news-releases/p95-acquires-4clinics-to-expand-global-cro-services-strengthen-position-as-market-leader-302188157.html